Should You Invest in the Vanguard Health Care ETF (VHT)?
Sector ETF report for VHT
The Vanguard Health Care ETF (VHT) was launched on 01/26/2004, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
Retail and institutional investors increasingly turn to passively managed ETFs because they offer low costs, transparency, flexibility, and tax efficiency; these kind of funds are also excellent vehicles for long term investors.
Additionally, sector ETFs offer convenient ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Broad is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 11, placing it in bottom 31%.
The fund is sponsored by Vanguard. It has amassed assets over $17.31 billion, making it one of the largest ETFs attempting to match the performance of the Healthcare - Broad segment of the equity market. VHT seeks to match the performance of the MSCI US Investable Market Health Care 25/50 Index before fees and expenses.
The MSCI US Investable Market Health Care 25/50 Index is made up of stocks of U.S. companies within the health care sector.
When considering an ETF's total return, expense ratios are an important factor, and cheaper funds can significantly outperform their more expensive counterparts in the long term if all other factors remain equal.
Annual operating expenses for this ETF are 0.10%, making it one of the least expensive products in the space.
It has a 12-month trailing dividend yield of 1.15%.
Sector Exposure and Top Holdings
It is important to delve into an ETF's holdings before investing despite the many upsides to these kinds of funds like diversified exposure, which minimizes single stock risk. And, most ETFs are very transparent products that disclose their holdings on a daily basis.
This ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio.
Looking at individual holdings, Johnson & Johnson (JNJ) accounts for about 7.19% of total assets, followed by Unitedhealth Group Inc. (UNH) and Pfizer Inc. (PFE).
Performance and Risk
So far this year, VHT return is roughly 19.81%, and is up about 20.36% in the last one year (as of 12/23/2021). During this past 52-week period, the fund has traded between $218.21 and $265.84.
The ETF has a beta of 0.79 and standard deviation of 21.14% for the trailing three-year period, making it a medium risk choice in the space. With about 455 holdings, it effectively diversifies company-specific risk.
Vanguard Health Care ETF holds a Zacks ETF Rank of 1 (Strong Buy), which is based on expected asset class return, expense ratio, and momentum, among other factors. Because of this, VHT is an excellent option for investors seeking exposure to the Health Care ETFs segment of the market. There are other additional ETFs in the space that investors could consider as well.
ARK Genomic Revolution ETF (ARKG) tracks N/A and the Health Care Select Sector SPDR ETF (XLV) tracks Health Care Select Sector Index. ARK Genomic Revolution ETF has $5.49 billion in assets, Health Care Select Sector SPDR ETF has $34.69 billion. ARKG has an expense ratio of 0.75% and XLV charges 0.12%.
To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.Get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Vanguard Health Care ETF (VHT): ETF Research Reports
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
Johnson & Johnson (JNJ): Free Stock Analysis Report
Pfizer Inc. (PFE): Free Stock Analysis Report
Health Care Select Sector SPDR ETF (XLV): ETF Research Reports
ARK Genomic Revolution ETF (ARKG): ETF Research Reports
To read this article on Zacks.com click here.